key: cord-0929646-8s7qw9gv authors: Rovnak, Joel; Perera, Rushika; Hopken, Matthew W.; Read, Jenna; Waller, Derrick M.; Cohrs, Randall J. title: The 17th Rocky Mountain Virology Association Meeting date: 2017-11-08 journal: Viruses DOI: 10.3390/v9110333 sha: 9b5a336dab77072af21829b37a7b8318ae1dec6d doc_id: 929646 cord_uid: 8s7qw9gv Since 2000, scientists and students from the greater Rocky Mountain region, along with invited speakers, both national and international, have gathered at the Mountain Campus of Colorado State University to discuss their area of study, present recent findings, establish or strengthen collaborations, and mentor the next generation of virologists and prionologists through formal presentations and informal discussions concerning science, grantsmanship and network development. This year, approximately 100 people attended the 17th annual Rocky Mountain Virology Association meeting, that began with a keynote presentation, and featured 29 oral and 35 poster presentations covering RNA and DNA viruses, prions, virus-host interactions and guides to successful mentorship. Since the keynote address focused on the structure and function of Zika and related flaviviruses, a special session was held to discuss RNA control. The secluded meeting at the foot of the Colorado Rocky Mountains gave ample time for in-depth discussions amid the peak of fall colors in the aspen groves while the random bear provided excitement. On behalf of the Rocky Mountain Virology Association, this report summarizes the >50 reports. As can be seen by a graph depicting the number of PubMed citations per year, advances in virology and prion studies are accelerating at a pace that makes it difficult for any individual to remain informed in areas outside one's specialty ( Figure 1 ). In addition, scientific meetings are continuing to focus on specific areas to maximize dissemination of information to select groups while general meetings that cover multiple fields are typically too large to permit prolonged informal discussion, especially with students and early-stage investigators. With these facts in mind, the Rocky Mountain Virology Association (RMVA) was formed to provide a venue that permitted formal presentations of current research in multiple areas of virology and prion biology in a venue that is sufficiently removed from major cities to ensure extended informal discussions and opportunities to establish/strengthen collaborations. Professional child daycare was provided to help enable attendance by individuals with young children, which provided an educational opportunity through the children's participation in attendance by individuals with young children, which provided an educational opportunity through the children's participation in a virus and prion themed performance during the formal poster session. Taken together, the 17th annual RMVA meeting ( Figure 2 ) upheld the tradition of presenting novel findings, summarized below, that spanned the fields of bio-informatics, host-pathogen interactions, immunology, therapeutics, replication of DNA and RNA viruses along with prion detection and disease propagation. attendance by individuals with young children, which provided an educational opportunity through the children's participation in a virus and prion themed performance during the formal poster session. Taken together, the 17th annual RMVA meeting ( Figure 2 ) upheld the tradition of presenting novel findings, summarized below, that spanned the fields of bio-informatics, host-pathogen interactions, immunology, therapeutics, replication of DNA and RNA viruses along with prion detection and disease propagation. bodies and legs. They were thus interested in characterizing interactions between the three viruses in the mosquito. In order to understand how coinfection impacts virus evolution, Aedes aegypti (Poza Rica, Mexico) were exposed to blood meals containing more than one Aedes-borne arbovirus. Specifically, mosquitoes were orally exposed to American strains of CHIKV (99659), DENV-2 (Merida), or ZIKV (PRVABC59) in single infections, as well as combinations of the three viruses as double and triple infections. Mosquitoes were held for 12 days extrinsic incubation, at which time mosquito saliva, salivary glands, legs and midguts were collected. Samples were processed for RNAseq on the Illumina HiSeq4000 platform. They analyzed changes to viral consensus sequences and virus population structure in single versus coinfected mosquito tissues. Overall, their data suggested that infection with more than one arbovirus simultaneously may affect virus evolution in Aedes aegypti mosquitoes. Rebekah C. Gullberg (Arthropod-borne and Infectious Diseases Laboratory, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) initiated a conversation about host lipids and their ability to alter the infectivity of dengue virus, serotype 2 particles. As obligate intracellular parasites with limited genetic capacity, viruses must find creative ways to use cellular resources for their replication. Rearranging the structure of cellular membranes is a key requirement for positive-strand RNA viruses. There are multiple ways to rearrange a phospholipid membrane, such as controlling its source (e.g., particular organelle) or by altering cellular lipid biosynthesis to concentrate or deplete a given lipid species. Dengue viruses are the most aggressive arthropod-borne positive-strand RNA viruses in the world. It is well understood that dengue virus type 2 (DENV2) alters fatty acid metabolism during infection in the mosquito and human hosts. Fatty acids are a key component of endoplasmic reticulum (ER) membranes utilized for the viral life cycle. The Perera lab showed that DENV specifically alters the content of unsaturated fatty acids (UFA) in cellular membranes. In order to accomplish this, DENV2 upregulates and recruits Stearoyl CoA-desaturase (SCD), the rate-limiting enzyme in UFA biosynthesis, early during infection to sites of viral replication. Knockdown and inhibition of SCD resulted in reduced viral titers. Furthermore, they found that in the absence of SCD activity, DENV2 was less infectious in the next round of infection which led to the hypothesis that the virus titer reduction was due to a change in the content of the lipid envelope, which produced immature particles. Despite the lack of virus-derived lipid biosynthetic machinery, DENV2 was able to drastically alter cellular lipid content by manipulating SCD expression and thus produce mature virions. Hence they speculate that UFA biosynthesis pathway is a promising target for therapeutic intervention. Nunya Chotiwan (Arthropod-borne and Infectious Diseases Laboratory, Department. of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) continued the conversation on host lipids during dengue virus infection and presented data on how the ceramide and dihydroceramide ratio could impair dengue virus serotype 2 infection of Aedes aegypti-derived cells. Sphingolipids (SPs) are bioactive molecules that play roles in the structural composition of cellular membranes and cell-signaling pathways. SPs have also been highlighted in many studies as a lipid metabolic pathway altered by flavivirus infection. In the metabolomics study of midguts from Aedes aegypti mosquitoes infected with dengue virus (DENV) type 2, The Chotiwan lab identified and reconstructed a significant proportion of the SP pathway. This was the first functional annotation and validation of the pathway. They observed an accumulation of precursors and downstream derivatives of ceramide (CER), a hub of the SP pathway, during DENV infection. The balance between CER and its precursor, dihydroceramide (DHCER), plays critical roles in membrane architecture, fluidity and function. Therefore, they investigated whether modulation of CER and DHCER levels and the CER/DHCER ratio would have an impact on DENV infection in Aedes aegypti-derived cells using loss-of-function studies and validated the changes in metabolites by tandem mass-spectrometry. Cells were treated with 4-Hydroxyphenyl Retinamide (4HPR) or long double-stranded RNA (dsRNA) to inhibit activity of or knockdown the expression of sphingolipid ∆-4 desaturase (DEGS), the enzyme that converts DHCER to CER. Inhibition of DESG by 4HPR showed significant reduction of virus titer and genome replication but did not alter CER/DHCER ratios. However, DESG expression knockdown Viruses 2017, 9, 333 5 of 26 by dsRNA reduced DENV infection and altered CER/DHCER ratios. These results indicated that functionality of DEGS is important for DENV infection and the balance of CER and DHCER is a potential target for disrupting DENV transmission in Aedes aegypti mosquitoes. Kirsten Krieger (Arthropod-borne and Infectious Diseases Laboratory, Department. of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) kept the "lipid-centric" conversation going and described how phosphatidylcholine-enriched membrane environments influenced the replication of dengue viruses. Dengue Viruses (DENV) are positive strand RNA viruses that account for almost 400 million infections annually making them the most aggressive arthropod-borne human pathogens in the world. Positive strand RNA viruses share the common characteristic of reorganizing host cellular phospholipid membranes to assemble their viral replication complexes (VRCs). Unfortunately, how these viruses regulate membrane reorganization is unknown. During DENV replication, dramatic changes occur in lipid biosynthesis, that have a significant impact on membrane architecture and cellular signaling pathways. Phosphatidylcholine (PC) is a major phospholipid component of many lipoproteins, and makes up about 50% of total phospholipid content in cellular membranes. PC is synthesized in the endoplasmic reticulum via two distinct pathways: the Kennedy pathway or the PEMT pathway. The Kennedy pathway, abundant in most tissues, includes a crucial step in which phosphocholine is converted to CDP-choline by the enzyme, CTP: phosphocholine cytidylyltransferase (CCTalpha). CCTalpha, encoded by the PCYT1A gene, is the rate-limiting enzyme for PC synthesis. Studies on Brome Mosaic Virus (BMV), another positive strand RNA virus, have shown that BMV stimulates PC synthesis at viral replication sites. It has also been documented that PC accumulates in DENV infected mosquitoes and mosquito cells as well as during Hepatitis C and poliovirus infection. Preliminary results by the Krieger lab supported their hypothesis that dengue virus uses the CCTalpha enzyme to increase and regulate phosphatidylcholine synthesis during viral replication in order to change the lipid composition of host cellular membranes to benefit the viral life cycle. Jenna Read (Arthropod-borne and Infectious Diseases Laboratory, Department. of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) provided an update concerning fatty acid chain elongation in human cells impacting on the replication of dengue virus, serotype 2. Dengue viruses (DENV) are arthropod borne viruses with widespread impact consisting of 390 million new cases every year. Due to a geographical shift in arbovirus spread, viruses such as West Nile, dengue, and now Zika are becoming increasing threats to the United States. In order to develop antiviral or therapeutic agents, it is important to understand how the virus interacts with the host to initiate infection, replication and transmission. As obligate parasites, viruses require metabolic resources from host cells for productive infection. Many viruses including DENV impact the flux from glucose to acetyl-CoA to feed fatty acid metabolism in infected cells. For this purpose, they hijack several enzymes responsible for the biosynthesis or degradation of fatty acids. Saturated very-long chain fatty acids (VLCF) are one group of fatty acids that are hijacked by many viruses. Mammals have seven elongase enzymes to synthesize saturated VLCFs. Preliminary data on dengue virus has indicated that Elongation of Long-Chain Fatty Acid Family Member 6 (ELOVL6) is important for virus replication. ELOVL6 has been identified as a rate limiting enzyme that catalyzes the elongation of saturated and unsaturated long-chain fatty acids. These fatty acids can be used as precursors for more complex cellular membrane lipid production. The Read lab is validating the role of this enzyme during dengue virus replication under the hypothesis that dengue virus requires ELOVL6 to increase membrane fluidity and support the formation of membrane-bound virus replication complexes, and that blocking the activity of ELOVL6 may be a potential avenue for antiviral intervention. Elena Lian (Arthropod-borne and Infectious Diseases Laboratory, Department. of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA) presented preliminary data on using fatty acid desaturase 2 (FADS2) enzyme activity as a control point to limit dengue virus serotype 2 replication. Dengue is an arthropod-borne viral disease with an estimated 400 million infections annually across the globe. Dengue fever is caused by dengue viruses (DENV) and despite the Viruses 2017, 9, 333 6 of 26 prevalence of this disease, there are currently no US Food and Drug Administration (FDA)-approved vaccines or antivirals. DENV has been shown to manipulate the host's lipid biosynthesis pathways, specifically that of unsaturated fatty acids, for the assembly and function of viral replication complexes. Lipids are also used as cell signaling molecules for purposes such as antiviral defense mechanisms. By controlling lipid biosynthesis, DENV can better evade the host's immune response. One of the major lipid pathways altered by DENV is alpha-linolenic acid and linoleic acid metabolism. Arachidonic acid is one of the products from this pathway, and is an inflammatory molecule involved in cell signaling. Since DENV incites an inflammatory response, this pathway is an ideal drug target. Fatty acid desaturase (FADS2) is the rate-limiting enzyme used to catalyze the pathway; therefore, it is a potential target to reduce DENV replication. Preliminary evidence indicated a reduction in DENV replication in human cells through the inhibition of FADS2. To test the hypothesis that inhibition of FADS2 will impede DENV replication by reducing the presence of arachidonic acid in the cell from linoleic acid metabolism, the Lian lab plans to further investigate how inhibition of FADS2, with an inhibitor and with siRNA, will affect DENV, as well as cellular viability and function. Stephanie Mills (Arthropod-borne and Infectious Diseases Laboratory, Department. of Microbiology, Immunology and Pathology and Department of Biological Sciences, Colorado State University, Fort Collins, CO, USA) discussed the potential of using Acyl-CoA thioesterases as restriction factors of dengue viruses. Although dengue viruses (DENV) infect over 400 million people per year, only a suboptimal vaccine exists, and other therapeutic options are unavailable. Previous studies indicate that DENV utilizes lipids to replicate in host cells and preliminary loss of function analyses of fatty acid metabolizing enzymes identified Acyl-CoA thioesterase-1 (ACOT-1) to significantly increase DENV particle release. ACOT-1, a 42 kDa enzyme which hydrolyzes C-12 to C-20 length Acyl-CoA fatty acids, has been shown to reduce sepsis and prevent diabetes. The Mills' lab analyzed the role ACOT-1 in the life cycle of DENV. They harvested Huh-7 cells infected with DENV at 3 h intervals for 48 h. Uninfected cells and UV-inactivated DENV-exposed cells were included as controls. They analyzed ACOT-1 protein levels compared to viral protein NS3 in cell lysates on western blots and also analyzed the impact of siRNA mediated knockdown of ACOT-1 on DENV RNA replication by electroporating a luciferase reporter-tagged viral replicon following siRNA treatment. Validation of ACOT-1 messenger RNA (mRNA) levels in knockdown and control cells were done by quantitative real-time polymerase chain reaction (qRT-PCR). Localization of ACOT-1 protein upon infection was determined using immunofluorescence microscopy. Although ACOT-1 mRNA levels were inconclusive, ACOT-1 protein levels increased and then spiked between 9 and 12 h post infection, before decreasing to base line levels 21 h post infection. DENV RNA levels increased five-fold above controls upon siRNA mediated knockdown of ACOT-1. However, unlike other fatty acid metabolizing enzymes in DENV infected cells, ACOT-1 did not co-localize with NS3 upon infection. Their results indicated there was an increase in DENV particle release and genome replication upon loss of ACOT-1 function. Therefore, ACOT-1 may be the first fatty acid enzyme that plays a protective role in host cells against DENV infection. Caroline Montgomery (Arthropod-borne and Infectious Diseases Laboratory, Department of Microbiology, Immunology and Pathology and Department of Biological Sciences, Colorado State University, Fort Collins, CO, USA) described her analysis of exosomes released from Zika virus infected cells as a paracrine signaling mechanism to prime neighboring cells for enhanced infection. Cell-to-cell communication has the capacity to enhance viral infection by releasing signaling molecules or vesicles from infected cells that prime recipient cells. One way these communication pathways can function is by giving an advantage to the virus as it replicates by priming the neighboring cells and making them more susceptible to infection. The signaling molecules can circulate in the host and give way to prolonged consequences of infection. These molecules are referred to as the secretome of cells and may contain lipids, nucleic acids and proteins and can be transported by extracellular vesicles. For example, fatty acid synthase (FAS), which is an important enzyme in lipid metabolic pathways, can be transported by extracellular vesicles to increase the metabolism of the recipient cells. FAS is required in the viral lifecycle, and through transport by these vesicles, it can metabolically Viruses 2017, 9, 333 7 of 26 activate the recipient cells and prime them for infection. Through this observation, it is suggested that infected cells can participate in paracrine signaling, thus enhancing viral replication in neighboring cells. Under the hypothesis that vesicles released by ZIKV infection will enhance the metabolism of neighboring cells, thus increasing the ability of ZIKV to replicate in these cells, the Montgomery lab presented preliminary data concerning secretome of ZIKV infected cells to determine whether they are able to participate in paracrine metabolic activation. Alison Gilchrist (Department of Molecular, Cellular, Developmental Biology and the Biofrontiers Institute, University of Colorado, Boulder, CO, USA) shifted the conversation to host protein targets predicted to be cleaved by the dengue virus protease. Dengue virus translates its genome into a single polyprotein and uses a self-encoded protease to cleave the polyprotein into individual proteins. The target site specificity for this protease is loose, so The Gilchrist lab anticipated that it also cleaved some host proteins in a manner that may be important for the viral life cycle. Using a machine learning approach, they have created a predictor to search for Dengue protease cleavage sites within the human proteome. They have experimentally validated that several human proteins in this candidate list were cleaved by the Dengue protease, and were important for replication. They provided insight now that each of these host-virus interactions may be acting as species-barriers in the movement of viruses between primate species, and which of these genes may be evolving rapidly in primate populations; information that was tested experimentally with different orthologs in Dengue infection assays. This project demonstrated how analysis tools from the field of molecular evolution could help facilitate novel characterization of host-virus biology. Abhilash Chiramel (National Institute of Health/Rocky Mountain Laboratories, Hamilton, MT, USA) introduced the audience to the concept that human TRIM5 protein could function as a host-derived restriction factor for flaviviruses. Tripartite motif (TRIM) proteins are interferon-inducible genes (ISGs) and function as virus-and host-specific restriction factors that can interact with viral proteins and inhibit viral replication. Flaviviruses, include globally significant human pathogens such as tick-borne encephalitis virus (TBEV), West Nile virus (WNV) and dengue virus. TBEV replication is inhibited by TRIM30D, a rodent-specific ISG that functions by binding and targeting the viral RNA polymerase (NS5) for lysosomal degradation. TRIM5 a retrovirus-specific restriction factor is the closest human paralog of TRIM30D. The Chiramel lab showed that both human (h) and rhesus (rh) TRIM5 restricted the replication of viruses belonging to the TBEV serogroup, but not WNV. Ectopic expression rhTRIM5 on TBEV significantly reduced the production of infectious virus by more than 99%. hTRIM5 overexpression imposed a 90% reduction of virus titer, whereas knock-down of hTRIM5 partially rescued the antiviral effects of interferon treatment. TRIM5 reduced production of both viral RNA and protein, indicating that TRIM5 targeted an early step in virus replication. However, unlike TRIM30D, TRIM5 did not interact with NS5 and instead interacts with and degrades NS3, an RNA helicase critical to virus replication, by a mechanism involving the proteasome. Moreover, TRIM5 colocalized with NS3 and dsRNA suggesting that TRIM5 disrupts the viral replication complex. This work demonstrated that TRIM5 could target two very different viral proteins, the human immunodeficiency virus (HIV) capsid, and the TBEV helicase. Understanding the genetic trade-offs in TRIM5 that enable restriction of one virus versus another will illuminate how the evolution of host resistance is shaped by multiple pathogens. Cody J. Warren (BioFrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, CO, USA) discussed his work on the cluster of differentiation 4 (CD4) receptor and how it restricts cellular entry of human immunodeficiency virus (HIV)-1 in nonhuman primates. Acute-stage isolates of HIV-1 require two receptors to enter cells, CD4 and C-C chemokine receptor type 5 (CCR5). The surface glycoprotein of HIV-1, Envelope (Env), mediates interaction with these two receptors facilitating virus entry into cells. The Warren lab showed that HIV-1 is highly adapted to use human CD4, and that nonhuman primate forms of CD4 restrict HIV-1 entry. Interestingly, HIV-1 poorly enters cells bearing even chimpanzee or gorilla CD4, despite the close relationship of these species to humans. They identified the reason why this important host Viruses 2017, 9, 333 8 of 26 restriction in nonhuman primates has been underappreciated to date: virions bearing Envs commonly used in SHIVs (SIV/HIV chimeric viruses), which are isolated from chronic-stages of infection and often are laboratory-adapted, efficiently infect cells expressing both human and nonhuman primate CD4 receptors. The finding that HIV-1 is highly adapted to humans in its use of CD4 has the potential to impact how HIV-1 infection and transmission is modeled in nonhuman primates. Joseph A. Westrich (Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA) provided evidence that the high-risk human papillomavirus E7 stabilizes the APOBEC3A protein by inhibiting Cullin-dependent protein degradation. Recent studies have revealed abundant APOBEC3 signature mutations in human papillomavirus (HPV)-positive cervical and head and neck cancers, suggesting a role in HPV-positive cancer progression. The Westrich lab and others have shown that A3A, a member of the APOBEC3 family, is upregulated in HPV-positive keratinocytes and cancer patient tissues. They sought to determine if the HPV oncoprotein E7 had a post-translational effect on the A3A protein, thus they determined A3A protein levels in human keratinocytes expressing various HPV E7s. They found that high-risk HPV (HPV16 and 18) E7s, but not low-risk HPV (HPV6 and 11) E7s, inhibit A3A proteasomal degradation, effectively stabilizing the A3A protein. This effect was mediated by the motifs in the domain of HPV16 E7 involved with interaction with Cullin 2 (CUL2), a core component of the E3 ubiquitin ligase complex. Knockdown of CUL2, or inhibition of Cullin activation, resulted in protecting A3A from degradation similar to high-risk E7-expressing cells. CUL2 was shown to interact with both A3A and E7, suggesting CUL2 as a key player in preventing A3A degradation. Using an in vitro cytidine deaminase assay, they showed that the A3A protein stabilized by HPV16 E7 maintained its enzymatic activity to deaminate cytidine. These findings that high-risk HPV E7 stabilizes A3A protein provide a new insight into virus-induced mutagenesis that may contribute to the generation of APOBEC3 mutation signatures observed in HPV-positive cancers. Emily Anne Kizer (University of Idaho, ID, USA) discussed the identification of novel antibiotics from satellite viruses. Increasing levels of drug resistance in human pathogenic yeasts stress the need for to develop new antifungal drugs. The Kizer lab has screened 216 yeasts from the Saccharomyces genus and identified 30 strains capable of producing protein toxins that inhibit the growth of fungi, including other Saccharomyces yeasts and several human pathogens from the genus Candida. They have found that 77% of these newly identified "killer yeasts" were infected with viruses from the Totiviridae family. Of these virus-infected killer yeasts, 93% contained double-stranded RNA (dsRNA) satellites, which have been previously shown to encode antifungal toxins. The molecular weight and copy number of these dsRNA satellites varies within each killer yeast. The antifungal toxins produced by each identified killer yeast have the ability to inhibit growth of a unique subset of Saccharomyces and pathogenic yeast strains. They hypothesized that sequence polymorphisms found within dsRNA satellites were responsible for the variation in toxin tropism. To explore the relationship between genotype and antifungal toxin efficacy, they developed a rapid method for dsRNA extraction and next-generation sequencing. Using this pipeline, they have successfully identified several novel totiviruses and toxin-encoding dsRNA satellites. The expressed cloned toxin genes from dsRNAs in the laboratory yeast S. cerevisiae, recapitulating their antifungal activity. This was the first study to investigate the role of dsRNA satellites in the production of antifungal toxins and to relate dsRNA satellite sequence to the killer yeast phenotype. Keith W. Jarosinski (Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Champaign, IL, USA) described his lab's studies to identify host-specificity during herpesvirus host-to-host transmission, with the overall goal of understanding the mechanism by which viral and host proteins facilitate efficient transmission from host-to-host. Transmission from host-to-host (interindividual spread) is an essential component in the herpesvirus' life cycle. Herpesviruses are typically associated with a single host species in nature, but when they Viruses 2017, 9, 333 9 of 26 transmit across species (interspecies spread), the outcome is often deadly. For example, the macaque herpes B virus causes fatal encephalitis when transmitted to humans, and Aujeszky's disease in cattle is caused by Suid alphaherpesvirus 1 (SuHV1), better known as pseudorabies virus (PRV), naturally found in pigs. However, very little is known about transmission of herpesviruses. He described his lab's successful work that culminated in identification of two herpesvirus proteins that are essential for interindividual spread of Gallid alphaherpesvirus 2 (GaHV-2), better known as Marek's disease virus (MDV), in chickens-namely, glycoprotein C (gC) that is conserved among the Alphaherpesvirinae subfamily and the conserved herpesvirus protein kinase (CHPK) conserved among all members of the Herpesviridae family. Myrna M. Miller (University of Wyoming, Wyoming State Vet Lab, Laramie, WY, USA) continued the theme of herpesviruses in natural hosts by presenting her group's study of seroprevalence of a novel mule deer-associated alphaherpesvirus in Wyoming. A previously unidentified alphaherpesvirus was found in juvenile mule deer (Odocoileus hemionus) that were submitted to the Wyoming State Veterinary Laboratory with infectious keratoconjunctivitis-like syndrome (IKC) and/or blindness. A retrospective analysis of IKC cases between 2000 and 2016 in mule deer found that 23% (4/17) were associated with this herpesvirus. Whole-genome sequencing of four isolates found that they were identical (>99.8% identity). Phylogenic analysis based on amino acid sequences for glycoproteins gB, gC, and gD showed this mule deer-derived herpesvirus (MDHV) is most closely related to ruminant alphaherpesviruses, including cervid herpesvirus-1 (CvHV-1, 93% identity), cervid herpesvirus 2 and bovine herpesvirus 1 (CvHV-2, BHV-1, 91% identity), BHV-5 and buffalo herpesvirus (90% identity), and caprine herpesvirus (86% identity). BHV-1 is the prototype for ruminant alphaherpesviruses and causes respiratory and reproductive syndromes in cattle, including rhinotracheitis, conjunctivitis, encephalitis, and abortion. The distribution and prevalence, as well as the range of clinical syndromes caused by MDHV, are currently unknown. A seroepidemiologic survey was performed to establish the prevalence of MDHV infection in three Wyoming herd units. Microtiter serum neutralization assays were used with mule deer serum against MDHV or BHV-1. The prevalence of anti-MDHV antibodies in these three herds was 84% (67/80, CI 90%, 77-91%), 90% (66/73, CI 90%, 84-96%), and 76% (68/89, CL 90%, 69-83%). Serologic cross-reactions with BHV-1 were detected, but titers were significantly lower (p values